[Halothane hepatitis. Possibilities of prevention].
作者信息
Døssing M, Andreasen B, Ranek L, Johansen S H
出版信息
Ugeskr Laeger. 1982 Feb 15;144(7):466-8.
PMID:7080249
Abstract
摘要
相似文献
1
[Halothane hepatitis. Possibilities of prevention].
Ugeskr Laeger. 1982 Feb 15;144(7):466-8.
2
Halothane hepatitis: a critical review.氟烷性肝炎：批判性综述。
Anesth Analg. 1972 Jan-Feb;51(1):135-60.
3
The clinical syndrome of halothane hepatitis.氟烷性肝炎的临床综合征。
Anesth Analg. 1969 Nov-Dec;48(6):1033-42.
4
[Halothane and liver toxicity].
Presse Med (1893). 1969 Mar 22;77(14):513-4.
5
Halothane hepatitis in children.儿童氟烷性肝炎
Anaesthesia. 1986 Jun;41(6):575-8. doi: 10.1111/j.1365-2044.1986.tb13045.x.
6
Unexplained hepatitis after podiatric surgery with halothane anesthesia.
J Am Podiatr Med Assoc. 1985 Jan;75(1):23-7. doi: 10.7547/87507315-75-1-23.
7
Halothane hepatitis in children.儿童氟烷性肝炎
Br Med J (Clin Res Ed). 1987 May 9;294(6581):1209-11. doi: 10.1136/bmj.294.6581.1209.
8
Hepatitis following halothane anesthesia.氟烷麻醉后肝炎
Pac Med Surg. 1967 Jan-Feb;75(1):28-32.
9
[Toxic hepatitis after halothane. 98 cases reported to the Danish Board on Adverse Reactions to Drugs].[氟烷所致中毒性肝炎。向丹麦药物不良反应委员会报告的98例病例]
Ugeskr Laeger. 1978 Apr 3;140(14):798-9.
10
Halothane: clinical considerations.氟烷：临床考量
Int Anesthesiol Clin. 1974 Summer;12(2):73-84.
引用本文的文献
1
Drug-induced hepatic disorders. Incidence, management and avoidance.药物性肝病。发病率、管理与预防
Drug Saf. 1993 Dec;9(6):441-9. doi: 10.2165/00002018-199309060-00007.
Zotero 插件